Growblox Sciences Inc. (GBLX) 1.0800 $GBLX
*UPDATE* Big Pharma And Medical Marijuana; How Can They Coexist?
ACCESSWIRE - Mon Aug 25, 9:04AM CDT
New York, NY / ACCESSWIRE / August, 25, 2014 / Everyone has been closely following the marijuana industry. Anywhere from accessories from companies like Vapor Group Inc. (OTCQB:VPOR) to actual growing operations, this market has been a hotbed for analysis and speculation. Of course as with many developing sectors, marijuana has a long way to go before we start hearing about FDA approvals and big business taking a stand. What we have seen thus far, however, is the emergence of brand new companies mostly trading on the OTC who are becoming the mavericks of the MJ marketplace and possibly leading the way for big business and more importantly, Big Pharma to follow.
GB Sciences, Inc. CEO Craig Ellins to Present on the Medical Marijuana Stocks Public Company Panel at The Money Show: Tune in and View it Live
GlobeNewswire - Thu Aug 21, 12:00PM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a medical marijuana research and development company, announced that CEO Craig Ellins will be presenting on the Medical Marijuana Stocks Public Company Panel at The Money Show on August 22, 2014, from 10:30am-11:30am PDT at the Hilton San Francisco Union Square. Mr. Ellins will be joined by 50+ other top industry service and product providers to discuss the emerging medical marijuana industry. The Company invites its shareholders and other interested parties to tune in and view the panel discussion live by registering for free at: http://www.moneyshow.com/eshow/san_francisco/...ode=035226
GB Sciences, Inc. Provides Update on Nevada State Licensing Applications
GlobeNewswire - Fri Aug 15, 6:00AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced they have completed and officially submitted 4 Nevada State license applications for 1 cultivation facility and 3 dispensaries as of August 13, 2014. The Company has already received a special use permit for a dispensary and cultivation facility in Clark County, Nevada. The special use permits issued by the County Commissioner's Office is expected to have some influence on the final State decision but does not guarantee State approval.
CSO Andrea Small-Howard, PhD of GrowBLOX Sciences, Inc. to Be Interviewed Live on Clear Channel Business Talk Radio - August 13th, 2014
Marketwire - Tue Aug 12, 9:42AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that Chief Science Officer (CSO) Andrea Small-Howard, PhD, MBA, will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. In this exclusive 2-segment interview, Dr. Small-Howard will discuss the science and research behind The Company's indoor agriculture technology that allows controlled growth for the manufacture of toxin-free, natural medicinal-grade cannabis. We encourage shareholders, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
GB Sciences, Inc. Announces the Arrival of the First GrowBLOX(TM) Cultivation Chamber in Las Vegas, Nevada
GlobeNewswire - Mon Aug 11, 6:07AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced today that the first GrowBLOX(TM) cultivation chamber has arrived in Las Vegas, Nevada. With the arrival of The Company's core technology, GB Sciences will be better prepared to commence its cultivation operations in Nevada; pending the upcoming Nevada State Licensing decision. Through its local, majority-owned subsidiary, GB Sciences Nevada, LLC, GB Sciences, Inc. is awaiting final license approval for one cultivation facility in Clark County, Nevada, and three medical marijuana dispensaries, two in the City of Las Vegas and one in Clark County, Nevada. GB Sciences has already received special use permits for one dispensary and one cultivation facility issued by the Clark County Commissioner's Office. The State is expected to make their decisions as early as this month, but no later than November 3, 2014.
CSO Andrea Small-Howard PhD of GrowBLOX Sciences, Inc. to Be Interviewed LIVE on Clear Channel Business Talk Radio -- August 13th, 2014
Marketwire - Fri Aug 08, 9:12AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that Chief Science Officer (CSO) Andrea Small-Howard, PhD, MBA, will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. In this exclusive 2-segment interview, Dr. Small-Howard will discuss the science and research behind The Company's indoor agriculture technology that allows controlled growth for the manufacture of toxin-free, natural medicinal-grade cannabis. We encourage shareholders, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
GB Sciences, Inc. Announces the First Fully Functional GrowBLOX(TM) Cultivation Chamber Has Arrived in the United States; Additional Units to Follow
GlobeNewswire - Mon Aug 04, 6:01AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a medical marijuana research and development company, announced the first fully functional model of their cutting-edge GrowBLOX(TM) Cultivation Chamber has arrived in the United States after being assembled in China. The GrowBLOX(TM) has landed in Los Angeles, California, and is expected to arrive in Las Vegas, Nevada, within one or two days. Additional units will follow soon thereafter.
GB Sciences, Inc. CEO Craig Ellins in High Demand as Medical Marijuana Industry Expert
GlobeNewswire - Thu Jul 31, 10:00AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced that CEO Craig Ellins is in high demand by top tier publications, reporters, and journalists as an expert in the medical marijuana industry. Recently, several highly respected media outlets have been contacting GrowBLOX Sciences, Inc. in hopes of landing an interview with CEO Craig Ellins to discuss a variety of different topics regarding the medical marijuana industry. Some of these topics include state legislation updates, license application processes, challenges faced by medical marijuana companies, efficacy standards for medical marijuana, and how to best capitalize on the rapidly growing medical marijuana industry to name a few.
GB Sciences, Inc. Announces the First GrowBLOX(TM) Cultivation Chamber Has Been Shipped to Las Vegas
GlobeNewswire - Tue Jul 29, 6:40AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced that the first GrowBLOX(TM) cultivation chamber has been shipped and is expected to land in Las Vegas, Nevada, within just a few days. The timing is perfect as The Company continues to receive high interest in their cultivation science and technology. For example, The Company recently announced a binding Memorandum of Understanding with LaurelCo, LLC (Chicago, Illinois) in which GB Sciences, Inc. licensed the use of their proprietary GrowBLOXgrowing chambers in exchange for a 20% equity interest. The MOU also included licenses for additional proprietary technologies, collectively termed "GrowBLOX Solutions", required for tissue culture, growing chambers, curing technology, proprietary extraction processes and creation of "GBLX"-branded, pharmaceutical-grade medical marijuana products.
Agritek Holdings, Inc Carves Out Attractive Niches in Cannabis Industry
ACCESSWIRE - Mon Jul 28, 8:21AM CDT
WHITEFISH, MT / July 28, 2014 / The U.S. cannabis industry grew 64% in 2013 and is expected to reach $2.34 billion in size by the end of 2014, according to ArcView Market Research. With a growing number of public companies capitalizing on the interest in the space, investors have no shortage of opportunities to put their capital to work, from established firms like GW Pharmaceuticals plc (NASDAQ: GWPH) to recent entrants to the market.
GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois
PR Newswire - Fri Jul 25, 11:07AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) is pleased to announce the execution of a binding Memorandum of Understanding ("MOU"
with LaurelCo, LLC, an Illinois limited liability company formed to pursue the acquisition of both cultivation and dispensary medical marijuana licenses in the state of Illinois. Pursuant to the MOU, GBLX will acquire a 20% equity interest in LaurelCo, LLC in exchange for licenses to use our proprietary GrowBLOXTM growing chambers, as well as all technology related to the machines and to various other proprietary technologies ("GrowBLOXTM Solutions" required for the cloning, growing, curing, and creation of pharmaceutical grade medical marijuana. Further, GBLX will provide technical assistance during the upcoming complex Illinois license application process. The MOU further provides that after LaurelCo, LLC has received one or more licenses in the state, GBLX will provide growing chambers for the LaurelCo, LLC's growing facilities, in exchange for an accelerated payback of actual costs, plus a 10% royalty interest going forward in any products created in the chambers and sold by the LaurelCo, LLC licensed entity.
GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas
PR Newswire - Wed Jul 23, 6:01AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX), a medical cannabis research and development company, announced today that it is filing for two medical marijuana dispensary locations in Las Vegas, Nevada. These locations are in addition to the Clark County, Nevada dispensary for which the company has received a special use permit, as previously announced.
Has the 2nd Rally Begun for GrowBLOX Sciences Inc.?
ACCESSWIRE - Tue Jul 22, 8:48AM CDT
Has the 2nd Rally Begun? Breaking News Says It's Likely
GrowBLOX Sciences Inc. Garnering the Attention of the Investment Community
ACCESSWIRE - Mon Jul 21, 9:18AM CDT
July 21, 2014 / With four separate revenue drivers, a unique first-of-its-kind technology, an individual proprietary cannabis strains and a presence within a growing list of states, GrowBLOX Sciences, Inc. has been garnering the attention of the investment community over the last few months. Not only has GBLX seen explosive highs nearly $3.50, but the recent pullback to lows of $1 may have opened an opportunity for new investment. After watching the trading from Friday's afternoon session, a deeper look at the company and the current industry climate are the main reasons for wanting to keep an eye on this company heading into the rest of the month.
GrowBLOX Sciences, Inc. CEO Updates Shareholders on Key Developments
PR Newswire - Mon Jul 21, 6:01AM CDT
To Our Shareholders,
GB Sciences Applying for Medical Marijuana Licenses in Illinois
PR Newswire - Fri Jul 18, 1:31PM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) a medical marijuana research and development company, is applying for licenses to grow and dispense in Illinois. The timing couldn't be better for GB Sciences because Illinois State "lawmakers have set final rules to allow medical marijuana in Illinois, opening the door for patients to apply for ID cards this fall and to start purchasing legal cannabis by next spring" as was reported in the Chicago Tribune on Wednesday, July 16. The state intends to approve a total of 21 licenses for cultivation and 60 for dispensaries by September 2014.
GrowBLOX Sciences, Inc. Enters the Florida Medical Marijuana Market
PR Newswire - Wed Jul 16, 6:01AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) a medical marijuana research and development company, is pleased to announce it has entered the Florida Medical Marijuana Market through its new subsidiary, GB Sciences Florida, LLC. With nearly 20 million residents, Florida is poised to be the biggest medical marijuana market outside of California. The National Cannabis Industry Association estimates medical marijuana will be a $785 million industry in Florida with multiple economic opportunities. In November, Florida voters will decide if they should allow widespread sale and use of medical cannabis by saying "yay" or "nay" on The Florida Right to Medical Marijuana Initiative, commonly known as Amendment 2. Early polls show that voters are likely to approve the ballot as all expectations are for a landslide approval. If and when Florida approves the bill, it will become the first state in the Southeast to do so.
GrowBLOX Sciences, Inc. Announces Insider Buying as Lazarus Investment Partners LLLP Acquires Additional Shares
PR Newswire - Mon Jul 07, 7:23AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX), a biotechnology and research company, today is pleased to announce that their largest investor, Lazarus Investment Partners LLLP, has acquired an additional 269,632 shares in the open market for an additional $322,000 investment. Lazarus, which already holds a 3,000,000 share investment at a price of $0.50, averaged up their position acquiring 199,632 shares at $1.19, 50,000 shares at $1.21, and 20,000 shares at $1.20 over a three day period from June 30, 2014, to July 2, 2014.
GrowBLOX(TM) Sciences, Inc. Represented at International Cannabinoid Research Society Symposium 2014
PR Newswire - Mon Jun 30, 6:00AM CDT
GrowBLOX(TM) Sciences, Inc. (OTCQB: GBLX) is represented at the 24th Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS 2014) by their Chief Science Officer and Member of the International Cannabinoid Research Society, Andrea L. Small-Howard, PhD, MBA. GBLX seeks co-development partners from ICRS 2014 to assist in their pursuit of the research, testing, and development of FDA-approved cannabinoid treatment options using the stable profile of phytocannabinoids present in the cannabis plant cultivated in their proprietary GrowBLOX(TM) controlled indoor growing system.
*UPDATE* Big Pharma And Medical Marijuana; How Can They Coexist?
ACCESSWIRE - Mon Aug 25, 9:04AM CDT
New York, NY / ACCESSWIRE / August, 25, 2014 / Everyone has been closely following the marijuana industry. Anywhere from accessories from companies like Vapor Group Inc. (OTCQB:VPOR) to actual growing operations, this market has been a hotbed for analysis and speculation. Of course as with many developing sectors, marijuana has a long way to go before we start hearing about FDA approvals and big business taking a stand. What we have seen thus far, however, is the emergence of brand new companies mostly trading on the OTC who are becoming the mavericks of the MJ marketplace and possibly leading the way for big business and more importantly, Big Pharma to follow.
GB Sciences, Inc. CEO Craig Ellins to Present on the Medical Marijuana Stocks Public Company Panel at The Money Show: Tune in and View it Live
GlobeNewswire - Thu Aug 21, 12:00PM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a medical marijuana research and development company, announced that CEO Craig Ellins will be presenting on the Medical Marijuana Stocks Public Company Panel at The Money Show on August 22, 2014, from 10:30am-11:30am PDT at the Hilton San Francisco Union Square. Mr. Ellins will be joined by 50+ other top industry service and product providers to discuss the emerging medical marijuana industry. The Company invites its shareholders and other interested parties to tune in and view the panel discussion live by registering for free at: http://www.moneyshow.com/eshow/san_francisco/...ode=035226
GB Sciences, Inc. Provides Update on Nevada State Licensing Applications
GlobeNewswire - Fri Aug 15, 6:00AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced they have completed and officially submitted 4 Nevada State license applications for 1 cultivation facility and 3 dispensaries as of August 13, 2014. The Company has already received a special use permit for a dispensary and cultivation facility in Clark County, Nevada. The special use permits issued by the County Commissioner's Office is expected to have some influence on the final State decision but does not guarantee State approval.
CSO Andrea Small-Howard, PhD of GrowBLOX Sciences, Inc. to Be Interviewed Live on Clear Channel Business Talk Radio - August 13th, 2014
Marketwire - Tue Aug 12, 9:42AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that Chief Science Officer (CSO) Andrea Small-Howard, PhD, MBA, will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. In this exclusive 2-segment interview, Dr. Small-Howard will discuss the science and research behind The Company's indoor agriculture technology that allows controlled growth for the manufacture of toxin-free, natural medicinal-grade cannabis. We encourage shareholders, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
GB Sciences, Inc. Announces the Arrival of the First GrowBLOX(TM) Cultivation Chamber in Las Vegas, Nevada
GlobeNewswire - Mon Aug 11, 6:07AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced today that the first GrowBLOX(TM) cultivation chamber has arrived in Las Vegas, Nevada. With the arrival of The Company's core technology, GB Sciences will be better prepared to commence its cultivation operations in Nevada; pending the upcoming Nevada State Licensing decision. Through its local, majority-owned subsidiary, GB Sciences Nevada, LLC, GB Sciences, Inc. is awaiting final license approval for one cultivation facility in Clark County, Nevada, and three medical marijuana dispensaries, two in the City of Las Vegas and one in Clark County, Nevada. GB Sciences has already received special use permits for one dispensary and one cultivation facility issued by the Clark County Commissioner's Office. The State is expected to make their decisions as early as this month, but no later than November 3, 2014.
CSO Andrea Small-Howard PhD of GrowBLOX Sciences, Inc. to Be Interviewed LIVE on Clear Channel Business Talk Radio -- August 13th, 2014
Marketwire - Fri Aug 08, 9:12AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) announced today that Chief Science Officer (CSO) Andrea Small-Howard, PhD, MBA, will be interviewed live by host Michael Yorba on Clear Channel Business Talk Radio's The Traders Network Show. In this exclusive 2-segment interview, Dr. Small-Howard will discuss the science and research behind The Company's indoor agriculture technology that allows controlled growth for the manufacture of toxin-free, natural medicinal-grade cannabis. We encourage shareholders, analysts, industry professionals and all interested parties to tune in and listen live via Clear Channel's nationally syndicated iHeart Radio stream.
GB Sciences, Inc. Announces the First Fully Functional GrowBLOX(TM) Cultivation Chamber Has Arrived in the United States; Additional Units to Follow
GlobeNewswire - Mon Aug 04, 6:01AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX), a medical marijuana research and development company, announced the first fully functional model of their cutting-edge GrowBLOX(TM) Cultivation Chamber has arrived in the United States after being assembled in China. The GrowBLOX(TM) has landed in Los Angeles, California, and is expected to arrive in Las Vegas, Nevada, within one or two days. Additional units will follow soon thereafter.
GB Sciences, Inc. CEO Craig Ellins in High Demand as Medical Marijuana Industry Expert
GlobeNewswire - Thu Jul 31, 10:00AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced that CEO Craig Ellins is in high demand by top tier publications, reporters, and journalists as an expert in the medical marijuana industry. Recently, several highly respected media outlets have been contacting GrowBLOX Sciences, Inc. in hopes of landing an interview with CEO Craig Ellins to discuss a variety of different topics regarding the medical marijuana industry. Some of these topics include state legislation updates, license application processes, challenges faced by medical marijuana companies, efficacy standards for medical marijuana, and how to best capitalize on the rapidly growing medical marijuana industry to name a few.
GB Sciences, Inc. Announces the First GrowBLOX(TM) Cultivation Chamber Has Been Shipped to Las Vegas
GlobeNewswire - Tue Jul 29, 6:40AM CDT
GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced that the first GrowBLOX(TM) cultivation chamber has been shipped and is expected to land in Las Vegas, Nevada, within just a few days. The timing is perfect as The Company continues to receive high interest in their cultivation science and technology. For example, The Company recently announced a binding Memorandum of Understanding with LaurelCo, LLC (Chicago, Illinois) in which GB Sciences, Inc. licensed the use of their proprietary GrowBLOXgrowing chambers in exchange for a 20% equity interest. The MOU also included licenses for additional proprietary technologies, collectively termed "GrowBLOX Solutions", required for tissue culture, growing chambers, curing technology, proprietary extraction processes and creation of "GBLX"-branded, pharmaceutical-grade medical marijuana products.
Agritek Holdings, Inc Carves Out Attractive Niches in Cannabis Industry
ACCESSWIRE - Mon Jul 28, 8:21AM CDT
WHITEFISH, MT / July 28, 2014 / The U.S. cannabis industry grew 64% in 2013 and is expected to reach $2.34 billion in size by the end of 2014, according to ArcView Market Research. With a growing number of public companies capitalizing on the interest in the space, investors have no shortage of opportunities to put their capital to work, from established firms like GW Pharmaceuticals plc (NASDAQ: GWPH) to recent entrants to the market.
GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois
PR Newswire - Fri Jul 25, 11:07AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) is pleased to announce the execution of a binding Memorandum of Understanding ("MOU"
with LaurelCo, LLC, an Illinois limited liability company formed to pursue the acquisition of both cultivation and dispensary medical marijuana licenses in the state of Illinois. Pursuant to the MOU, GBLX will acquire a 20% equity interest in LaurelCo, LLC in exchange for licenses to use our proprietary GrowBLOXTM growing chambers, as well as all technology related to the machines and to various other proprietary technologies ("GrowBLOXTM Solutions" required for the cloning, growing, curing, and creation of pharmaceutical grade medical marijuana. Further, GBLX will provide technical assistance during the upcoming complex Illinois license application process. The MOU further provides that after LaurelCo, LLC has received one or more licenses in the state, GBLX will provide growing chambers for the LaurelCo, LLC's growing facilities, in exchange for an accelerated payback of actual costs, plus a 10% royalty interest going forward in any products created in the chambers and sold by the LaurelCo, LLC licensed entity. GrowBLOX Sciences, Inc. Files for Two Additional Medical Marijuana Dispensaries in Las Vegas
PR Newswire - Wed Jul 23, 6:01AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX), a medical cannabis research and development company, announced today that it is filing for two medical marijuana dispensary locations in Las Vegas, Nevada. These locations are in addition to the Clark County, Nevada dispensary for which the company has received a special use permit, as previously announced.
Has the 2nd Rally Begun for GrowBLOX Sciences Inc.?
ACCESSWIRE - Tue Jul 22, 8:48AM CDT
Has the 2nd Rally Begun? Breaking News Says It's Likely
GrowBLOX Sciences Inc. Garnering the Attention of the Investment Community
ACCESSWIRE - Mon Jul 21, 9:18AM CDT
July 21, 2014 / With four separate revenue drivers, a unique first-of-its-kind technology, an individual proprietary cannabis strains and a presence within a growing list of states, GrowBLOX Sciences, Inc. has been garnering the attention of the investment community over the last few months. Not only has GBLX seen explosive highs nearly $3.50, but the recent pullback to lows of $1 may have opened an opportunity for new investment. After watching the trading from Friday's afternoon session, a deeper look at the company and the current industry climate are the main reasons for wanting to keep an eye on this company heading into the rest of the month.
GrowBLOX Sciences, Inc. CEO Updates Shareholders on Key Developments
PR Newswire - Mon Jul 21, 6:01AM CDT
To Our Shareholders,
GB Sciences Applying for Medical Marijuana Licenses in Illinois
PR Newswire - Fri Jul 18, 1:31PM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) a medical marijuana research and development company, is applying for licenses to grow and dispense in Illinois. The timing couldn't be better for GB Sciences because Illinois State "lawmakers have set final rules to allow medical marijuana in Illinois, opening the door for patients to apply for ID cards this fall and to start purchasing legal cannabis by next spring" as was reported in the Chicago Tribune on Wednesday, July 16. The state intends to approve a total of 21 licenses for cultivation and 60 for dispensaries by September 2014.
GrowBLOX Sciences, Inc. Enters the Florida Medical Marijuana Market
PR Newswire - Wed Jul 16, 6:01AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX) a medical marijuana research and development company, is pleased to announce it has entered the Florida Medical Marijuana Market through its new subsidiary, GB Sciences Florida, LLC. With nearly 20 million residents, Florida is poised to be the biggest medical marijuana market outside of California. The National Cannabis Industry Association estimates medical marijuana will be a $785 million industry in Florida with multiple economic opportunities. In November, Florida voters will decide if they should allow widespread sale and use of medical cannabis by saying "yay" or "nay" on The Florida Right to Medical Marijuana Initiative, commonly known as Amendment 2. Early polls show that voters are likely to approve the ballot as all expectations are for a landslide approval. If and when Florida approves the bill, it will become the first state in the Southeast to do so.
GrowBLOX Sciences, Inc. Announces Insider Buying as Lazarus Investment Partners LLLP Acquires Additional Shares
PR Newswire - Mon Jul 07, 7:23AM CDT
GrowBLOX Sciences, Inc. (OTCQB: GBLX), a biotechnology and research company, today is pleased to announce that their largest investor, Lazarus Investment Partners LLLP, has acquired an additional 269,632 shares in the open market for an additional $322,000 investment. Lazarus, which already holds a 3,000,000 share investment at a price of $0.50, averaged up their position acquiring 199,632 shares at $1.19, 50,000 shares at $1.21, and 20,000 shares at $1.20 over a three day period from June 30, 2014, to July 2, 2014.
GrowBLOX(TM) Sciences, Inc. Represented at International Cannabinoid Research Society Symposium 2014
PR Newswire - Mon Jun 30, 6:00AM CDT
GrowBLOX(TM) Sciences, Inc. (OTCQB: GBLX) is represented at the 24th Annual International Cannabinoid Research Society Symposium on the Cannabinoids (ICRS 2014) by their Chief Science Officer and Member of the International Cannabinoid Research Society, Andrea L. Small-Howard, PhD, MBA. GBLX seeks co-development partners from ICRS 2014 to assist in their pursuit of the research, testing, and development of FDA-approved cannabinoid treatment options using the stable profile of phytocannabinoids present in the cannabis plant cultivated in their proprietary GrowBLOX(TM) controlled indoor growing system.
